Shire Biotech Denmark ApS: Financial statements 2014
CVR: 33358008
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 7,151,469 and a net result of DKK 342,653 compared with DKK 231,818 the year before. That is an increase of 50.5% compared with the year before. Equity in the 2014 report amounted to DKK 903,240. The solvency ratio was 23.6%.
- Gross Profit
- DKK 7,151,469
- Profit/Loss
- DKK 342,653
- Equity
- DKK 903,240
- Total Assets
- DKK 3,823,407
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 7.2M | 343K | 903K | - |
| 2013 | - | 4.8M | 232K | 561K | - |
| 2012 | 4.1M | 4.1M | 93K | 329K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Shire Biotech Denmark ApS has published its annual report for 2013. Gross profit came to DKK 4,752,701, and the net result was DKK 231,818.
As of April 8, 2014, Helen Rosemary Janaway has joined the board of directors of Shire Biotech Denmark ApS.
As of April 8, 2014, Michael Thomas Garry has left the board of directors of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company has been dissolved on 1 April 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SHIRE DENMARK ApS and ApS STAKE NR. 1347. The company has 0 employees (2018). In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity in the 2017 report amounted to DKK 3,207,794.